Search companies

Live

IMEXHS LIMITED (ASX: IME)

Health care · News and insights

Price unavailable

Latest IME announcements

IMEXHS revenue rises 23% as AI tools enter live use, but software bookings fall

2026-10-28 · Health care

IME: $0.330 +3.13% · MC: $19M

IMEXHS reported quarterly revenue growth of 23% and year-to-date revenue growth of 19%, while year-to-date underlying EBITDA more than doubled from the prior corresponding period. Its scheduling and image-suggestion AI agents moved into live production, and a transcription agent reached production readiness; however, new software recurring revenue fell from the previous quarter and software ARR was flat as churn offset new contracts. Cash increased from the previous quarter, while debt declined.

Updated 2026-10-28 10:40
Share
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments